Recombinant Integration host factor subunit beta (ihfB)

Shipped with Ice Packs
In Stock

Description

Recombinant Production Methods

Recombinant ihfB is typically expressed in E. coli using plasmid systems. Key steps include:

  1. Cloning: ihfB is inserted into expression vectors under inducible promoters (e.g., T7 or pL) .

  2. Co-Expression: IhfA and IhfB are co-expressed to ensure functional heterodimer formation .

  3. Purification: Affinity chromatography (e.g., His-tag systems) yields high-purity protein .

Challenges: Overexpression of IhfB alone leads to aggregation, necessitating co-expression with IhfA .

Role in Virulence and Pathogenesis

  • Pathogenicity Islands (PAIs): In E. coli, IhfB stabilizes PAI I by modulating integrase (intI) expression. Deletion of ihfB increases PAI loss by 40% .

  • Virulence Factors: In Vibrio cholerae, IhfB deficiency reduces cholera toxin (CT) production and tcpA expression by >50% .

  • Biofilm Formation: ihfB knockout in Dickeya zeae disrupts biofilm formation, critical for plant pathogenesis .

Table 2: Impact of ihfB Deletion on Bacterial Phenotypes

OrganismPhenotype ObservedMechanismSource
SalmonellaReduced SPI-1/SPI-2 gene expressionAltered DNA bending at promoters
Vibrio fluvialisLoss of T6SS2-mediated antibacterial activityImpaired hcp secretion
E. coli (UPEC)Destabilized PAI IDysregulated intI repression

DNA Replication and Genome Organization

  • Replication Initiation: IhfB binds oriC (replication origin) in E. coli, facilitating initiation complex assembly .

  • Nucleoid Condensation: Bends DNA nonspecifically to compact chromatin, aiding genome organization .

Biotechnological Applications

  • Phage Packaging: Enhances λ-phage DNA maturation by bending cos sites .

  • Gene Editing: Used in synthetic biology to optimize site-specific recombination systems .

Regulatory and Evolutionary Insights

  • Cross-Species Compatibility: Pseudomonas putida IhfB functionally complements E. coli mutants, despite 6-residue length differences .

  • Expression Dynamics: IhfB levels peak during the exponential-to-stationary phase transition, aligning with virulence gene activation .

Future Directions

  • Drug Targeting: IhfB’s role in virulence makes it a candidate for anti-infective therapies .

  • Synthetic Biology: Engineering IhfB variants with altered DNA-binding specificities could optimize gene circuits .

Q&A

What is recombinant Integration host factor subunit beta (ihfB)?

Recombinant Integration host factor subunit beta (ihfB) is one of the two homologous subunits that compose the heterodimeric bacterial DNA-binding protein complex known as Integration Host Factor (IHF). The ihfB protein is encoded by the ihfB gene, which in Escherichia coli K12 is located at genomic position 0.96 Mb. When produced through recombinant DNA technology, ihfB can be expressed, purified, and studied independently of its natural bacterial context. This approach allows researchers to investigate its structural properties, DNA-binding capabilities, and functional interactions with greater control and specificity than would be possible in the native system. Recombinant ihfB is particularly valuable for investigating how this protein facilitates site-specific recombination, DNA replication, and transcription regulation in bacterial systems.

How does ihfB functionally interact with bacterial DNA?

The ihfB subunit, in conjunction with ihfA, forms the IHF complex that interacts with bacterial DNA through two primary mechanisms. First, IHF recognizes and binds to specific DNA sequences, typically containing a consensus motif. Second, upon binding, IHF induces a dramatic bend in the DNA structure, estimated to be approximately 160-180 degrees. This DNA bending is crucial as it brings distant DNA regions into proximity, facilitating interactions between proteins bound at these regions. The bending mechanism is essential for various cellular processes including site-specific recombination, where it helps position recombination enzymes correctly, and transcription regulation, where it can influence RNA polymerase binding and activity. The ihfB subunit contributes specific amino acid residues that interact with the minor groove of DNA, providing both sequence specificity and structural changes necessary for proper functioning of genetic processes.

What are the standard methods for expressing recombinant ihfB?

When expressing recombinant ihfB, researchers typically employ a systematic experimental design approach based on established protocols for bacterial protein expression. The most effective method involves:

  • Vector selection: pET expression systems are commonly used, with the ihfB gene inserted under control of a strong, inducible promoter (typically T7).

  • Host strain optimization: E. coli BL21(DE3) or derivatives are preferred as expression hosts due to their deficiency in key proteases and compatibility with T7 expression systems.

  • Expression conditions: Optimal expression is typically achieved by growing cultures at 37°C until OD600 reaches 0.6-0.8, followed by induction with ISOPROPYL β-D-1-THIOGALACTOPYRANOSIDE (IPTG) at concentrations between 0.1-1.0 mM.

  • Temperature adjustment: Post-induction temperature reduction to 16-25°C often improves soluble protein yield by slowing protein synthesis and folding.

  • Codon optimization: Since ihfB contains rare codons, either codon optimization of the gene or use of hosts supplying rare tRNAs may be necessary.

This methodological approach ensures consistent production of functional recombinant ihfB protein for subsequent purification and analysis.

How can researchers verify the activity of purified recombinant ihfB?

Verifying the activity of purified recombinant ihfB requires a multi-parameter approach to assess both structural integrity and functional capacity. The following methodological workflow is recommended:

  • Electrophoretic Mobility Shift Assay (EMSA): This primary activity test measures DNA-binding capacity by observing migration retardation of labeled DNA fragments containing known IHF binding sites when incubated with purified ihfB (typically in combination with ihfA to form the complete IHF complex).

  • DNA bending assay: Using circular permutation analysis, researchers can quantify the angle of DNA bending induced by the reconstituted IHF complex, with active ihfB contributing to approximately 160-180° bends.

  • In vitro recombination assay: For functional verification, assess the ability of reconstituted IHF (including purified ihfB) to facilitate site-specific recombination in a controlled system using purified components.

  • Structural verification: Circular dichroism spectroscopy should be employed to confirm proper secondary structure formation, as misfolded ihfB will show altered spectral characteristics compared to the native protein.

These complementary approaches provide comprehensive verification of both structural and functional integrity of the purified recombinant ihfB protein.

What are the key structural differences between ihfA and ihfB subunits?

FeatureihfA SubunitihfB Subunit
Molecular Weight~11.2 kDa~10.6 kDa
DNA-binding MotifContains conserved proline at position 65Contains conserved proline at position 64
β-ribbon ArmsSlightly shorter arm regionExtended β-ribbon arm for DNA minor groove interaction
C-terminal RegionMore flexibleMore structured
DNA Sequence RecognitionContributes to recognition of 5' portion of binding sitePrimarily recognizes 3' portion of consensus sequence
Dimerization InterfaceContains more hydrophobic residuesContains more polar interactions

These structural differences create an asymmetric heterodimer that enables the IHF complex to recognize specific DNA sequences and induce the precise DNA bending angles required for its biological functions. The distinct properties of ihfB are particularly important for its role in facilitating site-specific recombination during phage integration and other cellular processes.

What experimental designs are most effective for studying ihfB-DNA interactions?

Investigating ihfB-DNA interactions requires sophisticated experimental designs that address multiple aspects of binding dynamics, specificity, and structural alterations. A comprehensive experimental approach should incorporate:

  • High-resolution structural studies: X-ray crystallography and cryo-electron microscopy of ihfB-DNA complexes provide atomic-level insights into protein-DNA contacts. Sample preparation should include co-crystallization trials with DNA fragments of varying lengths (20-35 bp) containing known binding sites.

  • Single-molecule techniques: Optical tweezers and magnetic tweezers experiments can directly measure the DNA bending induced by ihfB/IHF in real-time. These approaches should employ DNA constructs with fluorescent markers flanking the binding site to visualize bending dynamics.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This method identifies protein regions involved in DNA binding by measuring changes in hydrogen/deuterium exchange rates upon complex formation. Experimental design should include time-course measurements (10 seconds to 60 minutes) to capture binding kinetics.

  • DNA footprinting with hydroxyl radical protection: This provides nucleotide-resolution mapping of ihfB contacts along the DNA. Experiments should compare native ihfB to mutant variants to identify critical binding residues.

  • Systematic mutagenesis coupled with binding assays: Creating an alanine-scanning library of ihfB mutants combined with quantitative binding assays (fluorescence anisotropy or surface plasmon resonance) can identify critical residues for DNA recognition and bending.

This multi-technique experimental design creates complementary datasets that together provide comprehensive understanding of the molecular basis of ihfB-DNA interactions, capturing both static structural features and dynamic binding properties.

How can contradictions in ihfB binding site data be systematically analyzed?

Resolving contradictions in ihfB binding site data requires a structured analytical framework that incorporates multiple parameters and methodological approaches. Researchers should implement:

  • Contradiction pattern classification: Apply the (α, β, θ) notation system where α represents the number of interdependent items (binding site features), β represents the number of contradictory dependencies identified by domain experts, and θ represents the minimal number of Boolean rules required to assess these contradictions. Most ihfB binding site analyses would typically begin with (2,1,1) class assessment before progressing to more complex scenarios.

  • Multi-dimensional data integration: Create a comprehensive database of ihfB binding sites from diverse experimental methods (ChIP-seq, SELEX, DNase footprinting) and annotate with metadata including experimental conditions, binding strength, and genomic context.

  • Statistical contradiction resolution: Employ Bayesian statistical approaches to evaluate the probability of true binding versus experimental artifacts. This requires establishing prior probability distributions based on sequence conservation and physical properties of validated binding sites.

  • Consensus sequence refinement: Use position weight matrices from validated binding sites to score putative sites, then systematically analyze outliers that contradict the consensus model to identify possible context-dependent binding modes.

  • Experimental validation pipeline: Design a standardized experimental protocol using at least three orthogonal methods (e.g., EMSA, footprinting, in vivo reporter assays) to test contradictory binding sites under identical conditions.

This systematic approach allows researchers to distinguish genuine biological variability in binding preferences from methodological artifacts, resulting in a more accurate and nuanced understanding of ihfB binding site requirements.

What methodological approaches are most effective for studying ihfB's role in bacterial gene regulation?

Investigating ihfB's role in bacterial gene regulation requires integrating multiple methodological approaches that capture both direct and indirect regulatory effects. An effective research strategy should incorporate:

  • Genome-wide binding profile analysis: Implement ChIP-seq experiments using epitope-tagged ihfB under various growth conditions, with careful experimental design including biological triplicates and appropriate controls. Data analysis should incorporate peak calling algorithms optimized for nucleoid-associated proteins.

  • Transcriptome analysis in ihfB mutants: Design RNA-seq experiments comparing wild-type, ihfB deletion, and ihfB point mutant strains under multiple environmental conditions. Time-course experiments following environmental shifts provide particular insight into dynamic regulatory roles.

  • In vitro transcription systems: Reconstitute transcription complexes with purified components (RNA polymerase, transcription factors, and ihfB/IHF) on template DNA containing promoters of interest. This controlled system allows precise measurement of ihfB's direct effects on transcription initiation and elongation.

  • DNA topology analysis: Implement DNA supercoiling assays using chloroquine gel electrophoresis to assess how ihfB affects local and global DNA topology, which indirectly influences gene expression patterns.

  • Single-cell gene expression analysis: Employ fluorescent reporter constructs and time-lapse microscopy to capture cell-to-cell variability in gene expression dependent on ihfB, revealing stochastic effects and population heterogeneity.

This comprehensive methodological approach provides a multi-level understanding of ihfB's regulatory functions, from direct physical interactions with DNA to genome-wide expression consequences and single-cell phenotypic effects.

How can I design experiments to investigate ihfB's role in bacteriophage integration?

Investigating ihfB's role in bacteriophage integration requires a carefully structured experimental design that addresses both mechanistic details and biological significance. A comprehensive approach should include:

  • In vitro integration assay system: Establish a reconstituted system using purified components including:

    • Recombinant ihfB and ihfA to form IHF complex

    • Purified phage integrase (e.g., λ Int protein)

    • Supercoiled DNA substrates containing attP and attB sites

    • Buffer conditions mimicking physiological environments
      Measure integration efficiency quantitatively using quantitative PCR to detect recombination products.

  • Structure-function analysis: Create a panel of ihfB mutants with alterations in:

    • DNA binding residues in the β-ribbon arms

    • Dimerization interface with ihfA

    • Flexible hinges involved in DNA bending
      Test each mutant's ability to support integration, correlating structural features with functional outcomes.

  • Single-molecule visualization: Implement total internal reflection fluorescence (TIRF) microscopy to directly observe:

    • Binding kinetics of fluorescently labeled ihfB to DNA substrates

    • DNA conformational changes induced by ihfB binding

    • Assembly of the complete integration complex in real-time

  • In vivo genetic approach: Design genetic complementation experiments where:

    • ihfB-null bacteria are transformed with plasmids expressing wild-type or mutant ihfB

    • Phage integration efficiency is measured under controlled infection conditions

    • Integration site selection is mapped genome-wide using next-generation sequencing

This multi-faceted experimental design allows researchers to determine both the mechanistic necessity of ihfB for integration and the specific structural features required for its function in this process.

What are the best approaches for studying the structural dynamics of ihfB-DNA complexes?

Studying the structural dynamics of ihfB-DNA complexes requires specialized techniques that capture both spatial and temporal dimensions of these interactions. A comprehensive methodological approach should include:

  • Time-resolved X-ray solution scattering (TR-SAXS/WAXS): This technique captures conformational changes in the ihfB-DNA complex at nanosecond to millisecond timescales. The experimental design should include:

    • Rapid mixing devices or laser-triggered conformational changes

    • Time points ranging from microseconds to seconds

    • Contrast variation studies to distinguish protein and DNA movements

    • Data analysis using singular value decomposition to identify structural intermediates

  • Single-molecule FRET (smFRET): This approach monitors distance changes between fluorophores placed at strategic positions within the ihfB protein and/or DNA substrate. Key experimental considerations include:

    • Strategic placement of donor/acceptor pairs at the protein-DNA interface

    • Surface immobilization strategies that preserve native dynamics

    • Millisecond time resolution to capture binding/unbinding events

    • Analysis of FRET efficiency histograms to identify conformational substates

  • Molecular dynamics simulations: Computational approaches complement experimental data by providing atomic-level insights into dynamics. Simulations should:

    • Begin with high-resolution crystal structures when available

    • Include explicit solvent and physiological ion concentrations

    • Sample microsecond timescales using enhanced sampling techniques

    • Validate predictions with experimental observables such as FRET distances

  • Nuclear magnetic resonance (NMR) relaxation dispersion: This technique detects excited states and chemical exchange processes. Experiments should:

    • Focus on methyl-TROSY approaches for the large ihfB-DNA complex

    • Measure relaxation parameters at multiple magnetic field strengths

    • Quantify exchange rates between bound and free states

    • Map dynamics onto structural models

This integrated approach provides a comprehensive view of ihfB-DNA complex dynamics across multiple timescales and spatial resolutions, revealing both the structural and energetic basis of function.

How can mutation studies of ihfB help understand its functional domains?

Systematic mutation studies of ihfB can reveal critical structure-function relationships when designed with proper controls and analytical frameworks. An effective experimental approach should include:

  • Alanine-scanning mutagenesis: Create a comprehensive library of single alanine substitutions throughout the ihfB sequence, with particular focus on:

    • Positively charged residues predicted to interact with DNA phosphate backbone

    • Proline residues in the conserved PROKG motif essential for DNA bending

    • Residues at the ihfA-ihfB dimerization interface

    • C-terminal domain residues involved in DNA minor groove recognition

  • Functional categorization assays: Test each mutant in multiple assays to classify functional defects:

    • DNA binding affinity using fluorescence anisotropy or SPR

    • DNA bending capacity using FRET-based sensors with labeled DNA

    • Heterodimer formation with ihfA using size exclusion chromatography

    • In vivo complementation of ihfB-null phenotypes

  • Structural impact analysis: Analyze how mutations affect protein structure using:

    • Circular dichroism spectroscopy to assess secondary structure changes

    • Thermal stability measurements to detect folding defects

    • Limited proteolysis to identify regions with altered flexibility

  • Quantitative data integration: Create structure-function maps by:

    • Plotting mutation effects against sequence position

    • Mapping sensitivity hotspots onto structural models

    • Calculating correlation coefficients between different functional assays

    • Classifying mutations into distinct mechanistic categories

This comprehensive mutational analysis can identify critical functional residues, distinguish between direct and indirect effects, and provide insights into how the primary sequence of ihfB determines its specialized functions in DNA binding, bending, and protein-protein interactions.

What experimental controls are essential when studying recombinant ihfB in heterologous systems?

When studying recombinant ihfB in heterologous systems, implementing rigorous experimental controls is essential to ensure valid and reproducible results. A comprehensive control strategy should include:

  • Expression system controls:

    • Empty vector control: Cells containing expression vector without ihfB gene to identify background effects

    • Inactive mutant control: Expression of catalytically inactive ihfB (e.g., P65A mutant) to distinguish between specific and non-specific effects

    • Expression level monitoring: Western blot verification of consistent expression levels across experiments

    • Solubility assessment: Comparison of soluble versus insoluble fractions to ensure proper folding

  • Purification quality controls:

    • Purity verification: SDS-PAGE and mass spectrometry to confirm >95% purity

    • Endotoxin testing: LAL assay to exclude bacterial contaminants that could confound results

    • Aggregation analysis: Dynamic light scattering to verify monodispersity

    • Activity conservation: Comparison of specific activity across purification batches

  • Functional validation controls:

    • Native IHF comparison: Side-by-side comparison with native IHF purified from bacteria

    • Reconstitution control: Verification that recombinant ihfB can form functional heterodimers with recombinant ihfA

    • Specificity control: Testing binding to both consensus and non-consensus DNA sequences

    • Competition assays: Using unlabeled DNA to verify specific binding in EMSA or other binding assays

  • System-specific controls:

    • Host factor knockdown: siRNA against host proteins that might interact with ihfB

    • Subcellular localization: Verification of proper localization using immunofluorescence

    • Time-course monitoring: Ensuring stable activity throughout the experimental timeframe

    • Dosage response: Testing multiple concentrations to identify potential threshold effects

This systematic approach to experimental controls ensures that observed effects can be confidently attributed to ihfB's specific activities rather than artifacts of the heterologous expression system or experimental procedures.

How can I design experiments to distinguish between direct and indirect effects of ihfB on gene expression?

Distinguishing between direct and indirect effects of ihfB on gene expression requires a multi-layered experimental approach that systematically isolates different mechanisms of action. An effective research design should incorporate:

  • Temporal resolution studies:

    • Implement time-course experiments following induction or deletion of ihfB

    • Use rapid RNA extraction methods (30 seconds to 30 minutes post-perturbation)

    • Apply mathematical modeling to categorize immediate (likely direct) versus delayed (likely indirect) responses

    • Confirm with pulse-chase labeling of newly synthesized RNA using 4-thiouridine

  • Chromatin occupancy correlation:

    • Combine ChIP-seq of ihfB with RNA-seq under identical conditions

    • Calculate statistical correlation between binding strength and expression changes

    • Implement sliding window analysis to detect distance-dependent effects from binding sites

    • Create binding site mutation strains to verify causality at selected loci

  • In vitro reconstitution:

    • Establish cell-free transcription systems with purified components

    • Systematically add or remove ihfB while monitoring transcription of target genes

    • Test the effect of ihfB on RNAP binding, open complex formation, and elongation rates

    • Compare results from supercoiled versus relaxed DNA templates

  • Genetic interaction mapping:

    • Create double mutants combining ihfB deletion with key transcription factors

    • Apply Bayesian network analysis to RNA-seq data from the mutant panel

    • Identify epistatic relationships that indicate pathway positioning

    • Validate key nodes in the network with targeted biochemical assays

This comprehensive approach allows researchers to construct a hierarchical model of gene regulation, distinguishing genes directly controlled by ihfB binding from those affected through secondary regulatory cascades or global changes in DNA topology.

What computational approaches can complement experimental studies of ihfB function?

Computational approaches provide powerful complements to experimental studies of ihfB function, offering predictions, structural insights, and system-level understanding. An integrated computational strategy should include:

  • Sequence-based analyses:

    • Profile Hidden Markov Models to identify distant ihfB homologs across bacterial species

    • Coevolutionary analysis using direct coupling analysis to predict residue interactions

    • Phylogenetic footprinting to identify conserved binding sites across related bacteria

    • Machine learning approaches to predict novel binding sites from sequence features

  • Structural bioinformatics:

    • Homology modeling of ihfB and IHF complex in species lacking crystal structures

    • Molecular docking simulations to predict binding to novel DNA sequences

    • Normal mode analysis to identify flexible regions important for DNA bending

    • Electrostatic surface mapping to analyze DNA binding interfaces

  • Molecular dynamics simulations:

    • All-atom simulations of ihfB-DNA complexes in explicit solvent (100-1000 ns)

    • Free energy calculations to quantify binding energetics to different sequences

    • Enhanced sampling methods (metadynamics, umbrella sampling) to characterize DNA bending pathway

    • Coarse-grained simulations to access longer timescales and larger systems

  • Network analysis approaches:

    • Construction of gene regulatory networks centered on ihfB-regulated genes

    • Topological analysis to identify network motifs and regulatory hubs

    • Boolean network modeling to predict system-level responses to perturbations

    • Integration of transcriptomic, proteomic, and metabolomic data into multi-level models

These computational approaches generate testable hypotheses, provide mechanistic explanations for experimental observations, and enable the integration of diverse data types into coherent models of ihfB function at molecular, cellular, and systems levels.

How can I design experiments to study the interplay between ihfB and other nucleoid-associated proteins?

Investigating the interplay between ihfB and other nucleoid-associated proteins (NAPs) requires experimental designs that capture both competitive and cooperative interactions. A comprehensive methodological approach should include:

  • Sequential and simultaneous binding studies:

    • Develop EMSAs with differentially labeled NAPs (ihfB, H-NS, Fis, HU)

    • Create DNA substrates containing overlapping or adjacent binding sites

    • Implement order-of-addition experiments to detect cooperative or antagonistic binding

    • Quantify binding constants under varying ratios of different NAPs

  • In vivo proximity mapping:

    • Apply protein-protein crosslinking followed by mass spectrometry (XL-MS)

    • Implement Split-GFP complementation to visualize protein associations in living cells

    • Use ChIP-reChIP to identify genomic regions co-bound by ihfB and other NAPs

    • Apply super-resolution microscopy to visualize NAP clustering within the nucleoid

  • Functional genomic screens:

    • Create combinatorial deletion strains (ihfB+NAP double mutants)

    • Perform RNA-seq to identify synergistic or antagonistic effects on gene expression

    • Use transposon insertion sequencing (Tn-seq) to map genetic interactions under stress conditions

    • Implement CRISPRi for inducible knockdown of multiple NAPs with temporal control

  • In vitro reconstitution of nucleoid-like structures:

    • Reconstitute chromatin with defined components on large DNA substrates (10-50 kb)

    • Implement real-time imaging using total internal reflection fluorescence microscopy

    • Measure DNA compaction, looping, and phase separation properties

    • Study how different combinations of NAPs affect DNA accessibility to enzymes

This multi-faceted experimental approach allows researchers to decipher the complex interactions between ihfB and other NAPs, revealing how they collectively organize the bacterial chromosome and regulate gene expression through both competitive and cooperative mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.